Related Experiment Video
Updated: Nov 26, 2025

Surgical Technique for Superior Cervical Ganglionectomy in a Murine Model
Published on: December 2, 2022
Cervical ganglioneuroma mimicking a carotid body tumour
Alexandra G Britten1, Payam Entezami1, Brent A Chang2
1Department of Otolaryngology Head and Neck Surgery, Louisiana State University in Shreveport, Shreveport, Louisiana, USA.
Abstract:
A 30-year-old woman was referred to the ear, nose and throat clinic by her primary care physician for a 10-year history of an asymptomatic, large, right-sided neck mass. On examination, the patient had a palpable, non-tender, five-by-four centimetre, mobile, right-sided level II neck mass. CT scan with intravenous contrast showed an enhancing mass with multiple fluid cavities, splaying the external carotid and internal carotid arteries, concerning for a carotid body tumour. Patient was then referred to interventional radiology for angiography and embolisation prior to definitive surgical excision. However, when the mass was then excised surgically, final pathology identified the mass as a ganglioneuroma. Patient recovered well postoperatively with some ptosis of the right eye and symptoms consistent with first bite syndrome, treated with conservative measures.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Blockers
Cranial Part of Parasympathetic Division
The vagus nerve (cranial nerve X) alone accounts for approximately 75...
Sympathetic Pathways: Sympathetic Chain Ganglia
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

